Standout Papers
- EAU Guidelines on Renal Cell Carcinoma: 2014 Update (2015)
- European Association of Urology Guidelines on Renal Cell Carcinoma: The 2019 Update (2019)
- European Association of Urology Guidelines on Renal Cell Carcinoma: The 2022 Update (2022)
- Pembrolizumab plus axitinib versus sunitinib monotherapy as first-line treatment of advanced renal cell carcinoma (KEYNOTE-426): extended follow-up from a randomised, open-label, phase 3 trial (2020)
- Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell carcinoma: extended 4-year follow-up of the phase III CheckMate 214 trial (2020)
- Comparison of Immediate vs Deferred Cytoreductive Nephrectomy in Patients With Synchronous Metastatic Renal Cell Carcinoma Receiving Sunitinib (2018)
- Nivolumab plus cabozantinib versus sunitinib in first-line treatment for advanced renal cell carcinoma (CheckMate 9ER): long-term follow-up results from an open-label, randomised, phase 3 trial (2022)
- Cabozantinib plus Nivolumab and Ipilimumab in Renal-Cell Carcinoma (2023)
Immediate Impact
4 by Nobel laureates 27 from Science/Nature 76 standout
Citing Papers
A vision–language foundation model for precision oncology
2025 StandoutNature
Tumour vasculature at single-cell resolution
2024 StandoutNature
Works of Thomas Powles being referenced
Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell carcinoma: extended 4-year follow-up of the phase III CheckMate 214 trial
2020 Standout
A phase II study of atezolizumab (atezo) with or without bevacizumab (bev) versus sunitinib (sun) in untreated metastatic renal cell carcinoma (mRCC) patients (pts).
2017
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Thomas Powles | 9634 | 6177 | 3957 | 233 | 11.5k | |
| Laurence Albigès | 10230 | 6270 | 4944 | 448 | 13.7k | |
| Sergio Bracarda | 7422 | 5689 | 4285 | 230 | 11.3k | |
| Axel Bex | 10516 | 7235 | 3441 | 335 | 14.2k | |
| Frédéric Rolland | 6597 | 4685 | 4228 | 141 | 11.3k | |
| Christine Chevreau | 9987 | 6252 | 6054 | 308 | 15.3k | |
| Daniel Y.C. Heng | 7356 | 4858 | 3315 | 134 | 9.1k | |
| Viktor Grünwald | 6560 | 5407 | 3976 | 320 | 10.1k | |
| Gary R. Hudes | 6724 | 6084 | 3485 | 101 | 10.5k | |
| I. Bodrogi | 6343 | 4241 | 3498 | 77 | 10.2k | |
| Brian Schwartz | 5784 | 7652 | 5154 | 143 | 14.2k |
All Works
Loading papers...